We are live on ! Find out more
OCMI

Oaktop Capital Management II Portfolio holdings

AUM $1.34B
1-Year Est. Return 114.5%
This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+114.5%
3 Year Est. Return
+223.73%
5 Year Est. Return
+264.71%
10 Year Est. Return
+1,370.55%
AUM
$465M
AUM Growth
-$13.8M
Cap. Flow
-$22.4M
Cap. Flow %
-4.82%
Top 10 Hldgs %
94.35%
Holding
18
New
Increased
1
Reduced
1
Closed

Top Buys

Rank Stock Value
1
MXIM
Maxim Integrated Products
MXIM
+$570K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$23M

Sector Composition

Rank Sector Weight
1 Technology 46.44%
2 Healthcare 38.79%
3 Industrials 3.98%
4 Consumer Discretionary 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$170M 36.45%
1,833,957
-241,843
-12% -$23M
LRCX icon
2
Lam Research
LRCX
$382B
$59.5M 12.78%
3,165,040
KLAC icon
3
KLA
KLAC
$275B
$47.4M 10.19%
4,007,500
MXIM
4
DELISTED
Maxim Integrated Products
MXIM
$43.5M 9.36%
727,375
+10,000
+1% +$570K
PRGS icon
5
Progress Software
PRGS
$1.55B
$26.7M 5.75%
612,526
EGAN icon
6
eGain
EGAN
$176M
$20.6M 4.44%
2,536,843
CEVA icon
7
CEVA Inc
CEVA
$1.01B
$19.3M 4.16%
793,836
ASPN icon
8
Aspen Aerogels
ASPN
$387M
$18.5M 3.98%
2,593,272
AMBR
9
DELISTED
Amber Road Inc
AMBR
$18.3M 3.93%
1,398,791
VMW
10
DELISTED
VMware, Inc
VMW
$15.5M 3.33%
92,500
DELL icon
11
Dell
DELL
$283B
$7.14M 1.54%
277,441
XLE icon
12
State Street Energy Select Sector SPDR ETF
XLE
$39.7B
$6.37M 1.37%
200,000
PETS icon
13
PetMed Express
PETS
$42.5M
$5.86M 1.26%
373,675
AXDX
14
DELISTED
Accelerate Diagnostics
AXDX
$3.55M 0.76%
15,500
INTC icon
15
Intel
INTC
$466B
$1.58M 0.34%
33,010
NTRP
16
DELISTED
Neurotrope, Inc. Common
NTRP
$937K 0.2%
116,845
ANIK icon
17
Anika Therapeutics
ANIK
$199M
$508K 0.11%
12,500
BBBY
18
Bed Bath & Beyond
BBBY
$473M
$335K 0.07%
32,825

Similar funds

Oaktop Capital Management II's Q2 2019 Portfolio in Review

As of Q2 2019, Oaktop Capital Management II held 18 positions worth $465M, down 2.9% from $479M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Oaktop Capital Management II withdrew a net $22.4M in Q2 2019, reducing 1 holding. Its largest reduction was Celgene Corp, cutting an estimated $23M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 46% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Oaktop Capital Management II added an estimated $570K to Maxim Integrated Products.

  • Oaktop Capital Management II added most to Maxim Integrated Products in Q2 2019, an estimated $570K increase.
  • Oaktop Capital Management II's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $23M.
  • Oaktop Capital Management II's ten largest holdings make up 94% of its $465M portfolio in Q2 2019.
  • Oaktop Capital Management II opened 0 new positions and closed 0 in Q2 2019.
  • Oaktop Capital Management II's portfolio value fell 2.9% quarter-over-quarter to $465M.

Based on Oaktop Capital Management II's 13F filing for Q2 2019, filed 7 Aug 2019.